跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRUQAP 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TRUQAP 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
TRUQAP 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Astrazeneca Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 26, 2024
Approval ID
a8c42c8d071318e0
Company
Astrazeneca Ab
Type
Standard
Approval Details
Approval Id
a8c42c8d071318e0
Drug Cima Aemps Name
TRUQAP 160 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1241820001
Holder Company Name
Astrazeneca Ab
Marketing Company Name
Astrazeneca Farmaceutica Spain S.A.
Holder Company Detail Path
/organization/astrazeneca-ab
Authorization Date
2024-07-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
160 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Astrazeneca Ab
Company Detail Path
/organization/astrazeneca-ab
Company Information
Pharmaceutical Company Name
ASTRAZENECA AB
Country Name
Spain
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Website
http://www.astrazeneca.se
Active Ingredients
CAPIVASERTIB
160 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 26, 2024
Approval ID
a8c42c8d071318e0
Type
Standard
Back to CIMA-AEMPS Approvals
